"The Roskamp Institute, convinced of the value of an anti-inflammation drug that has shown promise, has taken over..." ~ CONVINCED
"...as part of the RELOCATION of roughly TWO DOZEN company employees, who will be housed at Roskamp's south Manatee County campus." ~ two dozen employees committed to moving 'across country' for a company convinced it can support them...hmmm.
"'There is a certain amount of risk involved,' Mullan said...'That risk is always built into any calculations you make.'" ~ the move and relocation of a couple dozen employees was calculated and worth the risk.
"the payoff could be huge: Prescription arthritis drugs alone represent a $15 billion annual market." ~ arthritis alone!
"...the strategy of the company, to see if we can develop them for a number of inflammatory disorders -- arthritis, ulcerative colitis, maybe some immune disorders." ~ interestingly, arthritis is listed again, and first...not to mention, they've received many, many testimonials on arthritis relief in recent years.
"Mullan hopes to file an application with the agency by the end of June, though the institute has yet to state which medical condition it intends to target." ~ only two months away...and i think i have an idea which condition they may target first. ;)
"Roskamp was drawn to Star Scientific primarily because of evidence that Alzheimer's disease has a strong inflammatory component to it." ~ original focus, and probable ultimate goal
that's a great sign to me. some good news, and rockcreek is not blaring it, not even talking about it...YET. when there is good news and a company is rather quiet, it tells me they are looking toward the news following through, and not counting on the news to propel the stock or gain a quick 'thrill'. i've seen companies that tout every tiny bit of good news...that concerns me a little.
"Star Scientific’s over-the-counter PRODUCT, Anatabloc, is, for now, sold at GNC outlets and online."
the anti-inflammatory DRUG is in the future.
read more slowly next time.
shares originally exercisable for a 60 month period, are now amended to restrict the time during which the warrants can be exercised to ONLY the 60th month. one would presume some other term would be altered to agree to this restriction, and yet, other terms remain unchanged.
"Except for the amendments noted above, the warrant terms remain unchanged."
good sign to me, as the largest shareholders express confidence in the future.
of course they're paid...everyone gets paid, yourself included, for being on this board. but the truth of the matter remains...Quintiles has helped develop or commercialize ALL of the top 50 best selling drugs on the market. get drum to help you understand.
it's comical how you belittle and mock everyone more intelligent and successful than you. you are the one at the bottom, crawling around and envious of all others. you are too funny!
well, if you did your homework, you would know that Chapman was with Quintiles from 1995 to 2000, and then began his own firm where he "served as Chairman and Chief Executive Officer of Chapman Pharmaceutical Consulting, Inc., which provides expert medical consultation on the development and management of domestic and global product development programs for biotech, pharmaceutical, and medical device products". He then became a board member of Star in 2005, and just recently became president upon seeing the potential with anatabine.
do your homework next time, drum.
interestingly, autism is generally not noticed until age 1-2...not at birth. if only the cdc would humble themselves and consider the vast increase in vaccinations given at these ages as numerous are given TOGETHER AT ONCE to a baby, oftentimes when an infant may already have a compromised immune system (a cold or something the body is already fighting), they might get a handle on the problem. at the very least, SPREAD the vaccinations out instead of giving five or six on the SAME day!
Quintiles is the largest provider of biopharmaceutical development and commercial outsourcing services.
With a network of more than 28,000 employees conducting business in approximately 100 countries, we have helped develop or commercialize all of the top 50 best selling drugs on the market.
RockCreek is using Quintiles services, if I recall correctly.
If only we knew someone with intimate ties to Quintiles.
If only someone like our new president, Christopher Chapman, had served with Quintiles. Oh he did?
Well, if only Chapman had served as DIRCTOR with Quintiles, wow, that would be even better. Oh, he did?
But imagine if Chapman had served as SENIOR Director of Medical Affairs with Quintiles. That would be some good news!
"How could the above post even been remotely related to my mother, stupid."
your mother's name is 'stupid'?
you sure keep a persistent, close eye on this message board! and as i've politely asked you before, please keep references to your mother out of these threads.
Treatment of Thyroiditis
A female patient, aged approximately 52, had been afflicted with Hashimoto's thyroiditis for approximately 5 years. The patient's condition had advanced to a state where the treating physician recommended a thyroid lobectomy. The patient orally ingested a tablet containing about 600 μg anatabine citrate, 20 times daily over a period of 30 days. At the conclusion of the treatment, inflammation of the thyroid was reduced to normal levels, such that the patient was no longer in need of a thyroid lobectomy. The patient continued the treatment for an additional 30 days, after which time the patient's voice distortion associated with thyroiditis was no longer present."
Use of Anatabine to Treat Epilepsy and Autism
"A 10-year old male patient, who was diagnosed with autism and a seizure disorder, had brain surgery and began rehabilitation the following month. About 4 months later, in addition to continuing rehabilitation, he began a course of treatment with 1.0 mg of anatabine three times per day. Over the course of 31/2 weeks the frequency of the patient's seizures decreased from one per day to approximately one per week. The patient also experienced cognitive benefits beginning approximately one week after the start of the anatabine treatment, with noticeable improvements daily. These benefits included improved communication and language skills and the ability to focus."
"The expressions "in one embodiment", "in a preferred embodiment", "in a particular embodiment", "in an advantageous embodiment" or the like often appear in the description of patent applications and are used to introduce a particular implementation or method of carrying out the invention."
not sure why it won't allow me, but there are perhaps hundreds of additional potential disorders listed within the beverage patent application. I tried to post numerous times, to no avail.
"Isolated forms of a compound of Formula I or IA (e.g., anatabine or S-(-)-anatabine) or salts thereof are useful for treating disorders...NFκB-mediated transcription is implicated in an enormous variety of maladies."
"In some embodiments, the disorder is an immune or autoimmune disorder. In some embodiments, the disorder is thyroiditis. In some embodiments, the disorder is arthritis, such as rheumatoid arthritis, primary and secondary osteoarthritis (also known as degenerative joint disease). In some embodiments, the disorder is a spondyloarthropathy, such as psoriatic arthritis, juvenile chronic arthritis with late pannus onset, and enterogenic spondyloarthropathies such as enterog
enic reactive arthritis, urogenital spondyloarthropathy, and undifferentiated spondylarthropathy. In some embodiments, the disorder is a myopathy, such as "soft tissue rheumatism" (e.g., tennis elbow, frozen shoulder, carpal tunnel syndrome, plantar fasciitis, and Achilles tendonitis).
In some embodiments, the disorder is diabetes, either type I diabetes or type II diabetes. In other embodiments the disorder is a gastrointestinal inflammatory disorder, such as an inflammatory bowel disease. Examples of inflammatory bowel disease include, but are not limited to, Crohn's disease, Barrett's syndrome, ileitis, irritable bowel syndrome, irritable colon syndrome, ulcerative colitis, pseudomembranous colitis, hemorrhagic colitis, hemolytic-uremic syndrome colitis, collagenous colitis, ischemic colitis, radiation colitis, drug and chemically induced colitis, diversion colitis, colitis in conditions such as chronic granulomatous disease, celiac disease, celiac sprue, food allergies, gastritis, infectious gastritis, enterocolitis (e.g., Helicobacter pylori-infected chronic active gastritis), and pouchitis."
i could be wrong, but i was imagining a smaller sized drink. Gatorade and similar drinks are larger and used for rehydration and quenching thirst. i see this potential drink with main emphasis on ease of anatabine ingestion and absorption, without the need for much quantity of beverage.
the 5 hour energy drink is fairly simplistic...a few vitamins, energy blend ingredients, and caffeine. the founder is now a billionaire because of it...with a B!!
Patent Application for Beverage Product
Publication Date: Feb 27, 2014
Assignees: Rock Creek Pharmaceuticals, Inc.
Beverage in a glass or plastic bottle, or can, consisting of anatabine, a vitamin (probably d), a flavoring agent, citrus juice, a stabilizing agent, and purified water.
once things get sorted out (and given the ok), i'm thinking 5 hour energy drink size bottles sold at large retailers (while simultaneously moving toward drug completion).